Latest news
FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS - OncLiveOncLive · Fri, 31 Jul 2026 07:00:00 GMTFDA Approves Game-Changer: Freeze-Dried Plasma Revolutionizes Emergency Care - DevdiscourseDevdiscourse · Wed, 29 Jul 2026 22:55:46 GMT